A fusion gene breakpoint cluster region (BCR)-ABL1 is commonly associated with chronic myeloid leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL). This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.